Huons Meditech, a medical device subsidiary of Huons Group, is accelerating its global expansion through active participation in international exhibitions and conferences.

The company (CEO Jin-suk Lee) announced on June 16 that it hosted a launch seminar for its aesthetic device Dermashine Pro and took part in a major symposium in Australia. The launch event was held on June 12 at Peppers Salt Resort & Spa in Kingscliff, NSW, in collaboration with Oceania distribution partner SurgeMed.

About 200 local healthcare professionals (HCPs) attended the seminar, where leading South Korean and international key opinion leaders (KOLs) introduced the Dermashine Pro treatment method. Dr. Hosung Choi of PIENA Aesthetic Medical Clinic garnered significant attention with an on-site demonstration of the device.

From June 13 to 15, Huons Meditech also participated in the Non-Surgical Symposium (NSS) in Gold Coast, Queensland—Australia’s largest conference dedicated to non-surgical and minimally invasive cosmetic medicine. At the event, the company conducted live demonstrations and clinical case presentations featuring Dermashine Pro alongside local KOLs.

Dermashine Pro is an aesthetic medical device known for its precise drug infusion capabilities and intuitive user interface. Following its recent approval by the Australian Therapeutic Goods Administration (TGA), Huons Meditech plans to accelerate its entry into both the Australian and broader global aesthetics markets.

“This year, we signed a distribution agreement for Dermashine Pro in Australia and New Zealand—regions where Korean aesthetics are highly regarded,” said CEO Lee Jin-suk. “Successfully hosting the launch seminar is a meaningful milestone. We will continue to build our global presence through exhibitions, conferences, and academic marketing.”

In parallel, Huons Meditech recently participated in WHX MIAMI 2025, held from June 11 to 13, where it showcased its extracorporeal shock wave lithotriptor ASADAL-M1 and Dermashine Pro. The company drew strong interest from visitors by highlighting the technological and clinical advantages of its devices.